Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_assertion type Assertion NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_head.
- NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_assertion description "[In non-small-cell lung cancer (NSCLC), the identification of oncogenic driver mutations led to the definition of different clinical entities with different therapeutic opportunities, as demonstrated in patients harboring EGF receptor (EGFR) mutations or anaplastic lymphoma kinase translocations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_provenance.
- NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_assertion evidence source_evidence_literature NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_provenance.
- NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_assertion SIO_000772 24134423 NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_provenance.
- NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_assertion wasDerivedFrom befree-2016 NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_provenance.
- NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_assertion wasGeneratedBy ECO_0000203 NP1120184.RAY-Zt6Vw2a-91awdFHKvivQ1KXDhC7bfFyaKDDcSNh8A130_provenance.